GAMMA Investing’s Pacira BioSciences PCRX Stock Holding History

GAMMA Investing’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$61.8K	Buy	2,467 +96	+4%	+$2.43K	﹤0.01%	2221
2026 Q2	$60.2K	Sell	2,371 -460	-16%	-$10.9K	﹤0.01%	2177
2026 Q1	$64K	Sell	2,831 -176	-6%	-$3.91K	﹤0.01%	2007
2025 Q4	$77.8K	Sell	3,007 -18	-0.6%	-$428	﹤0.01%	1759
2025 Q3	$78K	Sell	3,025 -669	-18%	-$16.4K	﹤0.01%	1688
2025 Q2	$88.3K	Hold	3,694	–	–	0.01%	1549
2025 Q1	$91.8K	Buy	3,694 +1,958	+113%	+$46.9K	0.01%	1333
2024 Q4	$32.7K	Buy	1,736 +179	+11%	+$3.14K	﹤0.01%	1986
2024 Q3	$23.4K	Buy	1,557 +219	+16%	+$3.74K	﹤0.01%	2014
2024 Q2	$38.3K	Buy	1,338 +932	+230%	+$26.5K	0.01%	1381
2024 Q1	$11.9K	Buy	406 +286	+238%	+$8.79K	﹤0.01%	1966
2023 Q4	$3.91K	Buy	+120	New	+$3.51K	﹤0.01%	2340

Other funds holding PCRX

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

DCM

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

GAMMA Investing's PCRX Position: Q3 2026 in Review

GAMMA Investing increased its Pacira BioSciences (PCRX) stake by 4% in Q3 2026, buying an estimated $2.43K and bringing the position to 2,467 shares worth $61.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

GAMMA Investing first reported a position in PCRX in Q4 2023 and has held it in 12 quarters since. The position peaked at $91.8K in Q1 2025. 6 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

GAMMA Investing held 2,467 shares of Pacira BioSciences worth $61.8K as of Q3 2026.
GAMMA Investing bought 96 Pacira BioSciences shares in Q3 2026, an estimated $2.43K.
Pacira BioSciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2221 holding.
GAMMA Investing first reported a position in Pacira BioSciences in Q4 2023 and has held it in 12 quarters since.
GAMMA Investing's Pacira BioSciences position peaked at $91.8K in Q1 2025.
6 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.